https://www.selleckchem.com/pr....oducts/alw-ii-41-27.
Together, these results suggest that bexarotene may be developed as a potential novel therapeutic drug to better suppress Cushing's disease.Quantitative acetyl-proteomics, a newly identified post-translational modification, is known to regulate transcriptional activity in different organisms. Neurospora crassa is a model ascomycete fungus maintained for biochemistry and molecular biology research; however, extensive studies of the functions of its acylation proteins have yet to be performed. In this study, using LC-MS/MS qualitativ
Aimer
Commentaire
Partagez
